Penumbra
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.About PEN
Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.
CEOAdam Elsesser
CEOAdam Elsesser
Employees4,500
Employees4,500
HeadquartersAlameda, California
HeadquartersAlameda, California
Founded2004
Founded2004
Employees4,500
Employees4,500
PEN Key Statistics
Market cap12.63B
Market cap12.63B
Price-Earnings ratio77.06
Price-Earnings ratio77.06
Dividend yield—
Dividend yield—
Average volume416.14K
Average volume416.14K
High today$325.03
High today$325.03
Low today$315.49
Low today$315.49
Open price$316.29
Open price$316.29
Volume857.16K
Volume857.16K
52 Week high$325.03
52 Week high$325.03
52 Week low$221.26
52 Week low$221.26
Stock Snapshot
With a market cap of 12.63B, Penumbra(PEN) trades at $322.44. The stock has a price-to-earnings ratio of 77.06.
On 2026-01-11, Penumbra(PEN) stock moved within a range of $315.49 to $325.03. With shares now at $322.44, the stock is trading +2.2% above its intraday low and -0.8% below the session's peak.
Trading activity shows a volume of 857.16K, compared to an average daily volume of 416.14K.
The stock's 52-week range extends from a low of $221.26 to a high of $325.03.
The stock's 52-week range extends from a low of $221.26 to a high of $325.03.
Analyst ratings
86%
of 21 ratingsBuy
85.7%
Hold
9.5%
Sell
4.8%
People also own
Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.